Work for Chembio Diagnostic, Inc.?

Claim Your Profile

Chembio Diagnostic, Inc. Logo Image

Chembio Diagnostic, Inc.

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2017 Annual Report and Form 10K

Chembio Diagnostic, Inc.

Chembio Diagnostic, Inc. has reached its limit for free report views.

Chembio Diagnostic, Inc. does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About Chembio Diagnostic, Inc.

51-200 Employees
Based in Medford, New York

Chembio Diagnostics, Inc. develops, manufactures, licenses and markets proprietary rapid diagnostic tests in the growing $8.0 billion point-of-care testing market. Chembio markets each of its DPP HIV 1/2 Assay, HIV 1/2 STAT-PAK Assay, and SURE CHECK HIV 1/2 Assay, with these Chembio brand names, in the U.S. and internationally both directly and through third-party distributors. The Company's SURE CHECK HIV 1/2 Assay previously has been exclusively sold in the U.S. as Clearview Complete HIV 1/2 Assay.

Ticker:
CEMI
Exchange:
NASDAQ (See More NASDAQ Companies)
Industry:
Diagnostic Substances (See More Diagnostic Substances Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol